Skip to search formSkip to main contentSkip to account menu

HP-128

Known as: HP 128, HP128 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

suronacrine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
HP-128-3 甲状腺乳頭癌のT1b症例におけるD2リンパ節郭清の妥当性についての検討(甲状腺1,ハイブリッドポスター,第109回日本外科学会定期学術集会)
2009
2009
HP-128-2 小児甲状腺癌の治療戦略(甲状腺1,ハイブリッドポスター,第109回日本外科学会定期学術集会)
2009
2009
HP-128-5 甲状腺未分化癌患者における白血球数とG-CSF値に関する検討(甲状腺1,ハイブリッドポスター,第109回日本外科学会定期学術集会)
2009
2009
HP-128-1 甲状腺濾胞癌および乳頭癌骨転移例の特徴(甲状腺1,ハイブリッドポスター,第109回日本外科学会定期学術集会)
2009
2009
HP-128-4 甲状腺癌におけるGalNAc-T3の発現の検討(甲状腺1,ハイブリッドポスター,第109回日本外科学会定期学術集会)
1991
1991
Potential Clinical Use of an Adrenergic/Cholinergic Agent (HP 128) in the Treatment of Alzheimer's Disease
A novel compound designated HP 128, which manifests adrenergic and cholinergic properties, was administered for 10 days to… 
Highly Cited
1989
Highly Cited
1989
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
The synthesis of a series of 9-amino-1,2,3,4-tetrahydroacridin-1-ols is reported. These compounds are related to 1,2,3,4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)